even without vaccine considiration, GSK is good business with price at multiyear bottom zone. Started in september trials on vaccine, later in oct progress would be more clear, still there are no factors for price go lower. Put tight stop loss under 37. Next support level is 35, so if 37 would be broken and retested - take short position.
İşlem kapandı: hedefe ulaştı
⋅
as described - short after 37 level worked very well, 10% profit!